The U.S. Centers for Disease Control and Prevention (CDC) has awarded a new Indefinite Delivery/Indefinite Quantity (IDIQ) Blanket Purchase Agreement to lllumina to acquire an assortment of next generation library preparation and sequencing consumables.
The action supports several CDC programs which currently own and operate the lllumina HiSeq, MiSeq and NextSeq Next Generation Sequencing Instruments to support their Advanced Molecular Detection (AMO) research needs.
This BPA will allow lllumina next generation sequencing (NGS) reagents and supplies to be ordered on a VISA purchase up to $25,000. “As CDC increases its commitment to develop new AMO tools to support the CDC mission there will be an increase in the procurement of AMO reagents and supplies over the next few years,” states the announcement. “This will reduce the burden on the lab branch staff and the administrative staff in PGO and OCFO. This BPA will represent the best value to the government because it will provide a mechanism for more consolidated purchasing, for better pricing, for more efficient and timely purchasing, and will reduce the administrative burden.”
The overall contract has as a cost ceiling of $5,000,000 for year one and up to $25,000,000 over the course of the agreement from Jan 2016 – Dec 2020.